KCNK9 and colon carcinoma: The results of the present study demonstrated a new antitumor mechanism of genistein that application of genistein downregulated KCNK9 expression and suppressed the malignant phenotype of colon carcinoma by suppressing the Wnt/β-catenin signaling pathway in vitro.